Nutritional epidemiological research has to deal with measurement errors and inter- and intra-individual variability, which are specific for each micronutrient. Public health decisions must rely on valid and precise estimates of micronutrient intake. There is a need to reach a consensus about the best available methods for assessing micronutrient intake at the population level. The European project EURopean micronutrient RECommendations Aligned (EURRECA) reviews all literature in regard to validation of methods used to assess intake of micronutrients and n-3 FA. In this review of literature, dietary methods used to assess intake of n-3 FA are presented. The effect of dietary fats on health and disease has been of interest for many decades. The various health benefits of consuming the long-chain n-3 PUFA (LC n-3 PUFA), particularly eicosa-pentaenoic acid EPA and docosahexaenoic acid (DHA), have been reported widely(Reference Sullivan, Williams and Meyer1). The LC n-3 PUFA are obtained predominantly from fish, seafood, meat and eggs(Reference Sullivan, Williams and Meyer1) and in recent years from enriched food products such as bread, milk, margarine and eggs(Reference Sullivan, Williams and Meyer1). The aim of the present paper was to review the validity of methods used to measure the usual n-3 FA intake of a population.
Methods of this review
A systematic literature search was performed in December 2007 and March 2008. The literature search was conducted in Medline OvidSP and EMBASE using the following terms: ‘fatty acids’; ‘assessment’; ‘correlat*’; ‘diet’; ‘energy’; ‘fish’; ‘history’; ‘marine’; ‘nutrient’; ‘oil’; ‘omega’; ‘omega-3’; ‘questionnaire*’; ‘recall’; ‘record’; ‘studies’; ‘validat’; ‘validation’ including MeSH-terms. In total, 5572 articles were selected using Medline Ovid SP, while 1314 were identified from EMBASE. A new search was conducted after new guidelines from EURRECA using the search terms: ‘validity’ or ‘validation study’ or ‘reproducibility’ or ‘replication study’ or ‘correlation coefficient’ or ‘correlational study’ # or ‘validity’/syn or ‘validation study’/syn or ‘reproducibility’/syn or ‘replication study’/syn or ‘correlation coefficient’/syn or ‘correlational study’/syn, in addition to those included of n-3 FA. The search was rerun in EMBASE, however, no further articles were included from this search.
To find the articles included in this review, the following exclusion criteria were used: (1) articles assessing exclusively macronutrients and/or energy; (2) studies describing the content of nutrients in foods, additives or contaminants; (3) studies in diseased or institutionalised persons exclusively; (4) articles presenting reference values for food consumption, nutrient intake, biochemical markers and anthropometric measurements; (5) articles establishing associations between food consumption, nutrient intake, biological variables, biochemical markers and anthropometric measurements; (6) studies relating diseases to food consumption or nutrient intake; (7) intervention studies and other therapeutic studies with nutrients or drugs related to the metabolism of these nutrients; (8) calibration studies focusing only on statistical methods; (9) studies evaluating the physiological effects of foods, nutrients and in relation to their genetic determinants; (10) studies in animals, written in other languages rather than English, Spanish, French, Italian, Portuguese and those without abstract in Pubmed. After reading the title or abstract of all these (n 6886) articles, thirty-seven articles were left. The literature lists in the selected papers were checked and more articles were included. Last, we asked other experts to suggest relevant papers. Two papers were identified after consulting others (EURRECA). In total, fourteen articles were included in the results, including twenty studies (sixteen validation studies and four calibration studies).
Methods used in the included studies
Validated dietary methods
Tables 1 and 2 show descriptive information of the selected articles for this analysis. In the fourteen articles included in the review, eleven different FFQ had been validated (some articles present validation of more than one instrument)(Reference Sullivan, Williams and Meyer1–Reference Sullivan, Brown and Williams9). All the FFQ were designed to capture the usual diet, however, the time period covered ranged from the habitual diet over the last 3 months(Reference Sullivan, Brown and Williams9) or the last 12 months(Reference Paalanen, Mannisto and Virtanen6). Some questionnaires specifically asked only about n-3 FA rich food(Reference Sullivan, Williams and Meyer1), while others covered the whole diet with 102–200 food items included in the questionnaire(Reference Hunter, Rimm and Sacks2, Reference Andersen, Solvoll and Johansson4–Reference Paalanen, Mannisto and Virtanen6, Reference Hodge, Simpson and Gibson7, Reference McNaughton, Hughes and Marks8, Reference Knutsen, Fraser and Beeson10). A dietary history questionnaire had been validated in one study(Reference Sasaki, Ushio and Amano11). Weighed records had been validated in four studies(Reference McNaughton, Hughes and Marks8, Reference Marckmann, Lassen and Haraldsdottir12–Reference Kuriki, Nagaya and Tokudome14) and 24-h recalls in one study(Reference Knutsen, Fraser and Beeson10).
FA, fatty acids; pub, publication; DHQ, diet history questionnaire.
* Adipose tissue samples/blood samples.
† Black/white subjects.
FA, fatty acids; ALA, α-linolenic acid; DHQ, diet history questionnaire; LC, long chain.
* Spearman correlation.
† Significant at P < 0·001.
‡ Marine intake of n-3 FA.
§ Significant at P < 0·05.
∥ Non-Hispanic blacks/non-Hispanic whites.
¶ Pearson correlation.
** Corrected after attenuation correction factor.
†† Corrected for the reliability coefficients of FFQ and phospholipids.
‡‡ Men/women.
§§ Deattenuated with the within-to-between person variance ratio for intake of FA.
∥∥ Pearson/Spearman correlations.
¶¶ Deattenuated, energy adjusted and log-transformed.
Applied reference methods
Adipose tissue biopsy (subcutaneous fat)
Adipose tissue FA were determined using chromatography and calculating the area under the curve for each of the FA. All the studies using FA in tissue reported the same procedure with only slight modifications(Reference Hunter, Rimm and Sacks2, Reference Andersen, Solvoll and Johansson4, Reference Knutsen, Fraser and Beeson10, Reference Marckmann, Lassen and Haraldsdottir12).
Serum or plasma lipids
After extraction and isolation, the serum/plasma phospholipids were quantified by GLC after methylation(Reference Hjartåker, Lund and Bjerve3, Reference Hodge, Simpson and Gibson7, Reference McNaughton, Hughes and Marks8, Reference Sasaki, Ushio and Amano11, Reference Kobayashi, Sasaki and Kawabata13, Reference Kuriki, Nagaya and Tokudome14). Some expressed the serum phospholipids as mg FA/l serum(Reference Hjartåker, Lund and Bjerve3), while most used percent of total FA methyl esters(Reference Andersen, Solvoll and Johansson4, Reference Tokudome, Imaeda and Tokudome5, Reference Sasaki, Ushio and Amano11, Reference Kobayashi, Sasaki and Kawabata13) or both(Reference Hodge, Simpson and Gibson7). For detailed descriptions, refer to each particular study.
Weighed records
Weighed records, whose number of recording days ranged from 3 to 28 d, were used as reference method in four studies(Reference Tokudome, Imaeda and Tokudome5, Reference Paalanen, Mannisto and Virtanen6, Reference McNaughton, Hughes and Marks8, Reference Sullivan, Brown and Williams9).
Classification and quality score system
The studies were classified into three different types of studies according to the reference method used: (1) the reference was a dietary assessment method, and the reference method assessed an intake of < 7 d; (2) the reference was a dietary assessment method, and the reference method assessed an intake of >7 d; (3) the reference method was a biomarker. The studies that were classified into groups 1 and 2 were referred to as calibration studies, while the studies classified into group 3 were considered as a validation study.
To assess the quality of the different calibration/validation studies, a quality score system was developed(Reference Serra-Majem, Frost Andersen and Henriquez-Sánchez15). The studies were scored according to sample size, statistics used, data collection, if seasonality was considered and whether supplements were included or not, and a total quality score was calculated. All the studies were ranked as average according to this quality score system, apart from two studies(Reference Marckmann, Lassen and Haraldsdottir12, Reference Kuriki, Nagaya and Tokudome14) that were ranked as poor. These two studies(Reference Marckmann, Lassen and Haraldsdottir12, Reference Kuriki, Nagaya and Tokudome14) were not included in the further judgement of the quality of the dietary assessment methods.
When judging the quality of the dietary assessment methods, evaluations were done for the FFQ and the weighed records separately. No consideration was given to 24-h recalls(Reference Knutsen, Fraser and Beeson10) and diet history questionnaire(Reference Sasaki, Ushio and Amano11) because there was only one validation study on each of these methods. For the quality rating of the dietary method, summarised crude and adjusted correlation coefficients were calculated according to which reference method was used and which FA was presented (Tables 3 and 4). The crude correlation coefficients (R crude) were calculated by adding all specific correlation coefficients from each study and then dividing by the number of studies included. The adjusted correlation coefficient (R adjusted) was calculated by several steps: first, for each study the correlations between the intake of a specific FA and the reference method were multiplied with the quality score of the specific study. Then these figures were summarised and divided by the total quality score (adding the specific quality score of the included studies). The summarised adjusted correlation for each FA according to the reference method used was classified into poor (r < 0·30), acceptable (r 0·30–0·50), good (r 0·51–0·70) and very good (r>0·70) and this is presented in Figs. 1 and 2.
DPA, docosapentaenoic acid; ALA, α-linolenic acid.
* R adjusted: correlations between intake and the reference method were multiplied with the quality score of the specific study. These figures were then totalled and divided by the total quality score (sum of the specific quality score of the included studies).
DPA, docosapentaenoic acid; ALA, α-linolenic acid.
* R adjusted: correlations between intake and the reference method were multiplied with the quality score of the specific study. These figures were then totalled and divided by the total quality score (sum of the specific quality score of the included studies).
Results
Details of the fourteen papers selected for inclusion are given in Table 1. In the presented studies, the numbers of participants varied from 24 to 4439. The age distribution ranged from 19 to 75 years, with mean ages from 30 to 40 years. In total, eleven different FFQ and the weighed records in four different settings (varying number of days and season) and one 24-h dietary recall were validated against subcutaneous fat, serum or plasma FA or other dietary methods.
Subcutaneous fat
Four different FFQ were validated against subcutaneous fat(Reference Hunter, Rimm and Sacks2, Reference Andersen, Solvoll and Johansson4, Reference Knutsen, Fraser and Beeson10). The crude correlation coefficients varied from 0·39 to 0·66 for α-linolenic acid (ALA), EPA and DHA. All the correlations were significant. Hunter et al. (Reference Hunter, Rimm and Sacks2) validated two FFQ against subcutaneous fat. When adjusting the correlations, a slight increase was observed for one FFQ, while no changes were observed for the other (Table 2). Only Andersen et al. (Reference Andersen, Solvoll and Johansson4) presented quartile agreement between intake of FA measured with FFQ compared with FA in adipose tissue, and found that men who consumed FA in the highest quartile had adipose tissue levels that were significantly higher than men who consumed FA in the lowest or next lowest quartile(Reference Andersen, Solvoll and Johansson4).
One study validated weighed records (3 × 7 d) against subcutaneous fat(Reference Marckmann, Lassen and Haraldsdottir12). Crude correlations were given for EPA (r 0·4) and DHA (r 0·66), with only DHA being significant.
Knutsen et al. (Reference Knutsen, Fraser and Beeson10) validated eight different 24-h recalls of intake of ALA, EPA and DHA against subcutaneous fat. They found high adjusted correlations of 0·68/0·62 (men/women) for ALA, while the correlations for EPA and DHA were lower (Table 2).
Blood
Five different FFQ were validated against erythrocytes, plasma or serum(Reference Sullivan, Williams and Meyer1, Reference Hjartåker, Lund and Bjerve3, Reference Andersen, Solvoll and Johansson4, Reference Hodge, Simpson and Gibson7, Reference McNaughton, Hughes and Marks8). Sullivan et al. (Reference Sullivan, Williams and Meyer1) validated FA estimated from a FFQ against both FA from erythrocytes and from plasma(Reference Sullivan, Williams and Meyer1). For intake of total n-3 PUFA, EPA and DHA estimated from the FFQ, the correlation coefficients were higher when validated against plasma FA compared with erythrocytes (n-3 PUFA, 0·54 v. 0·50; EPA, 0·54 v. 0·40; DHA, 0·48 v. 0·39); however, all the correlations were significant(Reference Sullivan, Williams and Meyer1). Andersen et al. (Reference Andersen, Solvoll and Johansson4), Hjartåker et al. (Reference Hjartåker, Lund and Bjerve3) and Hodge et al. (Reference Hodge, Simpson and Gibson7) reported significant correlations of approximately 0·50–0·60 between dietary intake of EPA and DHA estimated from the FFQ and concentrations of EPA and DHA in serum or plasma. McNaughton et al. (Reference McNaughton, Hughes and Marks8) observed a lower correlation coefficient of both EPA (r 0·21) and DHA (r 0·32), but only the last was significant. Hjartåker et al. (Reference Hjartåker, Lund and Bjerve3) also presented relative weight of EPA and DHA in serum phospholipids according to quartiles of fatty fish filet frequency consumption and reported significant increases in serum phospholipids with increasing quartile of fatty fish filet measured with the FFQ(Reference Hjartåker, Lund and Bjerve3).
One dietary history questionnaire was also validated against serum FA and high crude and adjusted correlations were reported for intake of EPA (r 0·64) for men(Reference Sasaki, Ushio and Amano11). This questionnaire was self-administered and was somewhat similar to a FFQ.
Three studies have validated weighed records (all with seven or more days) against serum or plasma FA(Reference McNaughton, Hughes and Marks8, Reference Kobayashi, Sasaki and Kawabata13, Reference Kuriki, Nagaya and Tokudome14). Kobayashi et al. (Reference Kobayashi, Sasaki and Kawabata13) presented a very high correlation coefficient for EPA, crude: r 0·75 and adjusted: r 0·89 and also good correlations for DHA and total n-3 FA from weighed records validated against serum FA. Kuriki et al. (Reference Kuriki, Nagaya and Tokudome14) obtained adjusted correlations for dietary intake of EPA measured with weighed records against plasma concentration of EPA (r 0·57) and for DHA (r 0·57), while McNaughton showed a correlation of 0·43 for DHA measured with weighed records validated against DHA concentration in plasma(Reference McNaughton, Hughes and Marks8). All the three studies presented low correlations for ALA(Reference McNaughton, Hughes and Marks8, Reference Kobayashi, Sasaki and Kawabata13, Reference Kuriki, Nagaya and Tokudome14).
Weighed records
Four FFQ were validated against weighed food records(Reference Tokudome, Imaeda and Tokudome5, Reference Paalanen, Mannisto and Virtanen6, Reference McNaughton, Hughes and Marks8, Reference Sullivan, Brown and Williams9). Tokudome et al. (Reference Tokudome, Imaeda and Tokudome5) and Paalanen et al. (Reference Paalanen, Mannisto and Virtanen6) showed non-significant correlation coefficients between dietary intake of total n-3 FA from the two methods(Reference Tokudome, Imaeda and Tokudome5, Reference Paalanen, Mannisto and Virtanen6), while Sullivan et al. (Reference Sullivan, Brown and Williams9) obtained significant correlations varying from 0·64 to 0·75 for total n-3 FA, EPA and DHA(Reference Sullivan, Brown and Williams9). McNaughton et al. (Reference McNaughton, Hughes and Marks8) also presented significant correlations (total n-3 FA, r 0·39; EPA, r 0·40; DHA, r 0·52)(Reference McNaughton, Hughes and Marks8), although somewhat lower than those observed by Sullivan et al. (Reference Sullivan, Brown and Williams9).
Tokudome et al. (Reference Tokudome, Imaeda and Tokudome5) demonstrated the percentage difference of FA intake estimated from 28 d of weighed records and a FFQ. For total n-3 PUFA the average difference was 5 %, for ALA − 6 %, and for EPA 22 % and DHA 18 %, the last two being significantly different(Reference Tokudome, Imaeda and Tokudome5). Paalanen et al. (Reference Paalanen, Mannisto and Virtanen6) presented the difference in the mean intakes measured with the FFQ and the food records, and found that n-3 PUFA in the FFQ were 149 and 188 % of what was observed with food records for men and women, respectively(Reference Paalanen, Mannisto and Virtanen6). McNaughton et al. (Reference McNaughton, Hughes and Marks8) presented the agreements between the weighed food records and the FFQ. For total intake of long-chain FA, there was an exact agreement of 42 %. For EPA and DHA the agreement was 42 and 51 %, respectively(Reference McNaughton, Hughes and Marks8). Sullivan et al. (Reference Sullivan, Brown and Williams9) presented quintile agreement between the FFQ and the food records based on n-3 PUFA intakes, and found that 49 % were classified into the same quintile(Reference Sullivan, Brown and Williams9).
In Tables 3 and 4, the crude and adjusted correlation coefficients are calculated for the FFQ and the weighed records according to the EURRECA scoring system. In addition to the four studies already excluded from this quality rating (the two studies ranked as poor, one study with a 24-h recall and one study with a diet history questionnaire), two studies had to be excluded because originally only adjusted correlations were presented(Reference Paalanen, Mannisto and Virtanen6, Reference Kuriki, Nagaya and Tokudome14). The results from Tables 3 and 4 are depicted in Figs. 1 and 2. The adjusted correlations between dietary intake of each FA and the FA from the reference method are presented according to reference method. For each reference method, the summarised adjusted correlations (R adjusted) for each FA were classified into poor, acceptable, good or very good (see Method). The numbers of studies in which the summarised crude and adjusted correlation were based on differ according to the reference method category. Figure 1 shows that the FFQ gave acceptable estimates for total n-3 FA, EPA and DHA when using biomarkers as the reference method. When using more than 7 d of records as the reference method the same results were observed. Using less than 7 d of records as the reference method the total intake of total n-3 FA, EPA and DHA was rated as very good and good, however, this only included one study. Figure 2 shows that weighed records gave acceptable estimates of total n-3 FA while estimates for DHA and EPA were qualified as good.
Discussion
In this review, sixteen validation studies and four calibration studies from fourteen papers were described. The newly developed EURRECA scoring system was used to evaluate the quality of the validation studies and the quality of the estimates from dietary assessment methods.
In a validation study, the reference method used should be as accurate as possible(Reference Andersen, Solvoll and Johansson4). A validation study is also called a relative validation/calibration study, when one dietary method is compared to another dietary method, most often FFQ v. several days of food records. The limitations with this approach are the considerable individual day-to-day variation, which reduces the possibility of obtaining a true measure of usual intake with few recording days, as well as reporting bias since both self-administered dietary assessment questionnaires and dietary records are based on self-reporting(Reference Andersen, Solvoll and Johansson4). FFQ often report an overestimated intake of energy and nutrients(Reference Paalanen, Mannisto and Virtanen6), while food records often underreport energy intake and nutrients(Reference Livingstone, Prentice and Strain16, Reference Black, Goldberg and Jebb17). An alternative to relative validations is biomarkers, whose primary advantage is that these measurements are objective and that the sources of errors for a biomarker and a dietary assessment method are independent(Reference Andersen, Solvoll and Johansson4). PUFA are largely exogenic, meaning that there is no synthesis of PUFA in the body and that intake in diet and supplements are the major source, making the correlations with biomarkers easier(Reference Hodge, Simpson and Gibson7, Reference Arab18). There are several choices of a biomarker for the measurement of LC n-3 PUFA, and those presented in this review were FA in adipose tissue, erythrocytes and plasma. Adipose tissue FA are generally considered the best source of assessing long-term FA intake(Reference Knutsen, Fraser and Beeson10, Reference Arab18). Erythrocytes may be a useful marker as they can provide an indication of the previous 120-d intake of LC n-3 PUFA(Reference Sullivan, Williams and Meyer1). Plasma FA reflect intake of FA over the past few days or more(Reference Hodge, Simpson and Gibson7).
Most of the included studies have presented the correlations. The correlation coefficients obtained from the validation studies can reflect the capability of the method to rank individuals according to FA intake.
Subcutaneous fat
FA estimated from four different FFQ(Reference Hunter, Rimm and Sacks2, Reference Andersen, Solvoll and Johansson4, Reference Knutsen, Fraser and Beeson10), one weighed record(Reference Marckmann, Lassen and Haraldsdottir12) and one recall(Reference Knutsen, Fraser and Beeson10) were validated against subcutaneous fat, which the literature describes as the best reference method. The correlation coefficients observed in all the studies were in the range 0·40–0·66 for ALA, EPA and DHA. Of the studies using subcutaneous fat as the reference, the study by Marckmann et al. (Reference Marckmann, Lassen and Haraldsdottir12) was ranked with a low quality score, while the others were ranked with average scores. Marckmann et al. (Reference Marckmann, Lassen and Haraldsdottir12) had a low score due to a small number of study participants. In summary, none of the dietary methods validated against subcutaneous fat and presented here seem to be superior than the others in relation to ranking the dietary intake of n-3 PUFA.
Blood
Dietary intake of n-3 PUFA estimated from five different FFQ(Reference Sullivan, Williams and Meyer1, Reference Hjartåker, Lund and Bjerve3, Reference Andersen, Solvoll and Johansson4, Reference Hodge, Simpson and Gibson7, Reference McNaughton, Hughes and Marks8), one diet history questionnaire(Reference Sasaki, Ushio and Amano11) and three weighed record studies(Reference McNaughton, Hughes and Marks8, Reference Kobayashi, Sasaki and Kawabata13, Reference Kuriki, Nagaya and Tokudome14) was validated against FA in serum, plasma or erythrocytes. Both FA in plasma, erythrocytes and serum are found to be good biomarkers of LC n-3 PUFA(Reference Sullivan, Williams and Meyer1, Reference Hjartåker, Lund and Bjerve3). The correlation coefficients observed between the intake of FA measured by most FFQ(Reference Sullivan, Williams and Meyer1, Reference Hjartåker, Lund and Bjerve3, Reference Andersen, Solvoll and Johansson4), the diet history questionnaire(Reference Sullivan, Williams and Meyer1), one of the weighed records(Reference Kuriki, Nagaya and Tokudome14)v. FA in blood parameters were at the same level (r 0·40–0·60). The best correlation was observed in the study by Kobayashi et al. (Reference Kobayashi, Sasaki and Kawabata13) comparing the dietary intake of FA from weighed records with FA in serum phospholipids (EPA, r 0·89). However, there was no clear tendency among the three studies comparing FA from weighed records with FA in blood(Reference McNaughton, Hughes and Marks8, Reference Kobayashi, Sasaki and Kawabata13, Reference Kuriki, Nagaya and Tokudome14) showing that this was the best way to measure intake of n-3 FA.
All the studies validated against blood samples were qualified as average except the one by Kuriki et al., which was classified as poor. Most correlation coefficients from the studies comparing dietary intake with FA in blood parameters were in the same range as the ones observed for FA in adipose tissue (r 0·40–0·60). There was one study with a lower correlation(Reference McNaughton, Hughes and Marks8) and one with a correlation higher than this range(Reference Kobayashi, Sasaki and Kawabata13). For ALA most studies presented low correlations between dietary intake and blood parameters.
The estimation of summarised crude correlations and adjusted correlations for all the validation studies of FFQ using biomarkers as the reference method indicates that the FFQ give acceptable values for total n-3 FA, EPA and DHA. The summarised crude and adjusted correlations for the two studies validating weighed records against biomarkers indicate acceptable estimates for total n-3 FA, while the estimates for EPA and DHA were good. As expected, the weighed records seem to be superior to the FFQ in reference to estimating intake of EPA and DHA. However, it is important to remember that only two studies were included for the weighed records (Fig. 2), therefore it is difficult to reach strong conclusions.
Weighed record
Four FFQ were validated against weighed food records(Reference Tokudome, Imaeda and Tokudome5, Reference Paalanen, Mannisto and Virtanen6, Reference McNaughton, Hughes and Marks8, Reference Sullivan, Brown and Williams9). All the studies were ranked as average according to the quality score. The studies indicated that the FFQ overreported an average intake of n-3 FA compared with weighed records. Two of the studies presented a relatively good classification and good correlation between the two dietary assessment methods(Reference McNaughton, Hughes and Marks8, Reference Sullivan, Brown and Williams9). Biomarkers were more accurate to rank individuals than different dietary methods. One limitation with food records is that subjects are prone to underestimate their food intake when they keep food records(Reference Livingstone, Prentice and Strain16), and that the true food consumption of n-3 FA most likely lies somewhere between the weighed records and the FFQ (see earlier Discussion).
The aim of this review was to evaluate the validity of methods used to measure the usual n-3 FA intake of a population. According to the systematic review, none of the dietary assessment methods used to assess n-3 FA seem to be superior to another. Most studies presented the correlation coefficients ranging from 0·40 to 0·60. By using the summarised weighed correlations suggested by EURRECA, it was indicated that the quality of total n-3 FA, EPA and DHA intake estimated from the FFQ was acceptable.
This review confirmed the view that the FFQ to assess n-3 FA should not be validated against another dietary method, and that validation studies of dietary methods for measuring intakes of n-3 FA could be improved.
Acknowledgements
The studies reported herein have been carried out within the EURRECA Network of Excellence (www.eurreca.org), financially supported by the Commission of the European Communities, specific Research, Technology and Development Programme Quality of Life and Management of Living Resources, within the Sixth Framework Programme, contract no. 036196. This report does not necessarily reflect the Commission's views or its future policy in this area. N. C. Ø. performed the literature search and wrote the manuscript and the draft was discussed and revised by L. F. A and L. S.-M. The authors have no conflict of interests to report.